A B S T R A C T Specific cellular and host tropism is a characteristic property of many viruses mediated by the interaction of viral attachment proteins with components of the plasma membrane of the cell. We have studied the binding of virus to cells quantitatively by using type 3 reovirus labeled with 125I and GH,Cj pituitary cells in culture. Binding was rapid at both 40 and 15°C and was stable over a 9-h period. Unlabeled virus inhibited binding of the labeled virus in a dosedependent manner. Scatchard analysis revealed 4,200 viral binding sites/cell with an apparent affinity of 1.2 X 10" M. Also, binding of type 3 reovirus was inhibited by antibodies directed against the viral hemagglutinin and partially inhibited by type 2 reovirus, but was unaffected by type 1 reovirus or a variety of other ligands that bind to receptors on GH4Cj cells.
INTRODUCTION
Viruses are well known to exhibit specific tissue tropism and have defined host ranges. This specificity is in part attributable to discrete protein moieties on the viral surface, termed viral attachment proteins, which mediate adsorption of virus to the host cells (1) . For many viral systems, these proteins are well characterPortions of this work were presented at the annual meetings of the American Society for Clinical Investigation, Washington, D.C., May 9, 1982 .
Received for publication 10 January 1983 and in revised form 3 March 1983. ized. Adsorption of virus is also dependent on properties of the plasma membrane of the host cell, and there is some evidence that viruses interact with specific proteins or receptors on the cell plasma membrane to initiate their infection (2) . However, little information is available about the nature of these viral receptors; their specificity and even their existence is debated (3) .
Most data regarding the possible existence of viral receptors have been derived from relatively indirect or qualitative studies, such as measurements of viral adsorption to host cells, immunofluorescence of viruses on the cell surface, or electron microscopy. By contrast, membrane receptors for numerous other ligands that affect cellular function, such as peptide hormones and neurotransmitters, have been quantitatively characterized (4) . The success of these studies has depended on the availability of a purified ligand that could be labeled to a high specific activity, and could be used to define specific binding sites (5) . In the present study, we have applied these techniques to demonstrate and quantitatively characterize the interaction of type 3 reovirus with pituitary cells in culture.
Reovirus is a double-stranded RNA virus. The tropism of reovirus is known to be determined by a surface protein of the virus, the hemagglutinin, and the role of this protein has been assessed using recombinant viruses derived from the wild types (6, 7) . Recently, binding of fluorescein-labeled reovirus to ependymal cells has been demonstrated (8) .
There are three naturally occurring serotypes of reovirus, designated 1, 2, and 3. In mice, type 1 reovirus is known to produce an ependymitis and to infect cells of the endocrine pancreas and anterior pituitary, which leads to the development of autoimmune syndrome associated with diabetes, runting, and the development of antibodies to insulin and growth hormone (9) . In vivo type 3 reovirus preferentially infects neurons, but can also infect endocrine cells (10) . GH4C1 are a clonal line of rat pituitary cells (11) (12) (13) GH4C1 cells were grown to confluency on 100-mm dishes in Ham's F10 media supplemented with 15% horse serum and 2.5% fetal calf serum. Cells were removed from plates by gently scraping with a rubber policeman, and washed three times in binding buffer containing 115 mM NaCl, 5.3 mM KCI, 1.4 mM CaCl, 0.8 mM MgSO4, 0.9 mM NaH2PO4, 5.5 mM dextrose, 50 mM Hepes, 1% bovine serum albumin (BSA, fraction V; Sigma Chemical Co., St. Louis, MO), pH 7.5. Cells were then aliquoted into polyethylene 12 X 75-mm tissue culture tubes. Either buffer or excess unlabeled virus (final concentration, 200 ug/ml) was added. Cells were incubated for 10 min at room temperature, and then placed on ice or in a 15°C waterbath. Next, 20,000 cpm of iodinated virus (2.0 ng) was added. The incubation tubes were agitated at 10-15-min intervals. Samples were taken at the designated time and washed in a large excess of 4°C phosphate-buffered saline (PBS), 1% BSA, pH 7.5. Cell-associated radioactivity was determined using a gamma counter (model 1290, Tracor Analytic Inc., Elk Grove Village, IL).
Competition of '251-virus binding by unlabeled virus, anti-hemagglutinin, antibodies, and other ligands. 7.5 X 104 GH4C1 cells were aliquoted into 12 X 75-mm plastic culture tubes. Amounts of unlabeled type 3 reovirus ranging from 5 ng/ml to 500 ,ug/ml were added to the cells and cells were incubated for 10 min at 22°C. Control cells were incubated with buffer only. Cells were then placed in a 15°C waterbath and 5,000 cpm of tracer (0.5 ng) was added to each sample. After a 1-h incubation, cells were washed with 2 ml of 4°C PBS containing 1% BSA and centrifuged at 262 g in a GLC-4 centrifuge using an H-1000 rotor (E. I. DuPont de Nemours & Co., Inc., Sorvall Instruments Div., Newtown, CT). Experiments to determine the ability of other ligands to block binding of '251-type 3 reovirus were performed in the same manner. Concanavalin A, epidermal growth factor (EGF),' and insulin were preincubated with GH4C1 cells at a concentration of 1 jg/ml. Vesicular stomatitis virus (VSV) was added at a concentration of 200 jig/ml. Types 1 and 2 reovirus were tested at a concentration of 300 gg/ml.
In order to determine the ability of monoclonal anti-hemagglutinin antibodies to block viral binding, 5,000 cpm of '251-virus in 10 jil was incubated with 15 jIl of diluted antibody or buffer for 20 min at 22°C in 12 X 75-mm tubes. Tubes were then placed in a 15°C waterbath; 75,000 GH4C1 cells suspended in 75 ul of viral binding buffer were added and tubes were incubated for an additional 90 min. Cells were washed and counted as described above.
RESULTS
When tracer quantities of virus were added to aliquots of GH4C1 cells, binding of 125I-reovirus was rapid at both 40 and 15°C (Fig. 1) . Equilibrium was reached at 60 min and was stable over the 9-h period of incubation. Nonspecific binding was determined by performing incubations in the presence of a 1,000-fold excess of unlabeled virus and it was 30% of the total tracer binding. Total and nonspecific binding was similar at both temperatures. In separate experiments, time points from 5 to 60 min were sampled; one-half maximal binding was noted at 20 min at 15°C (data not shown).
The ability of unlabeled virus to compete with labeled virus that binds to GH4C1 cells was studied at 15°C using variable amounts of unlabeled virus. Complete inhibition of specific binding occurred at a concentration of 100-200 ,g/ml of unlabeled virus.
To determine the "apparent" binding affinity and number of receptors per cell and to allow comparison of the viral receptor to receptors for other ligands, Scatchard analysis (15) was performed (Fig. 2, inset) . The Scatchard plot was somewhat curvilinear; for the purpose of this analysis, however, only a single class of high affinity sites was analyzed. From the slope of the line, the apparent affinity (KD) of the virus for the cells was 1.2 X 10 '" M and there were 4,200 high l Abbreviations used in this paper: EGF, epidermal growth factor; VSV, vesicular stomatitis virus. (Fig. 3 A) . Of the two other naturally occurring serotypes of reovirus, type 1 at a concentration of 300 ug/ml had no effect on binding of labeled type 3, whereas type 2 at the same concentration produced about a 50% inhibition of that seen with type 3. VSV, another RNA virus, had no effect on reovirus binding. Similarly insulin, EGF, and concanavalin A, which have receptors on GH4C1 cells, had no effect. 8 The hemagglutinin on the viral particle has been shown to be responsible for its attachment to cells. Monoclonal antibodies directed against the viral hemagglutinin have been prepared and characterized by Burstin (16) . Antibody F-4 is known to block the ability of type 3 virus to agglutinate human erythrocytes; antibody G-5 blocks the ability of type 3 virus to infect L cells; and antibody H-3 immunoprecipitates the purified hemagglutinin, but has no effect on either hemagglutinating capacity or infectivity. As can be seen in Fig. 3 
